Filing Flows › Pfizer (PFE) › Net income
Pfizer (PFE) net income by quarter
Pfizer's net income was $3.3B in Q3 2026 (third quarter 2026), +21% from Q1 2026. Over the last 5 quarters it ranged from $2.7B (Q1 2026) to $3.5B (Q3 2025).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $3.3B | +21% | -8% |
| Q1 2026 | $2.7B | -24% | -9% |
| Q3 2025 | $3.5B | +22% | — |
| Q2 2025 | $2.9B | -2% | — |
| Q1 2025 | $3.0B | — | — |
Q3 2026 at a glance
Pfizer, Q3 2026: revenue $16.6B (-0.4% year over year), operating margin 20.4%, net earnings $3.3B, operating cash flow $5.4B. The chart follows the revenue to costs, profit and cash.
Questions
What is Pfizer's net income?
Pfizer's net income was $3.3B in Q3 2026 (third quarter 2026), +21% from Q1 2026.
How has Pfizer's net income changed?
Over the last 5 quarters it ranged from $2.7B (Q1 2026) to $3.5B (Q3 2025).